Annual Revenue
$3.62 B
+$712.50 M+24.49%
31 December 2023
Summary:
DexCom annual revenue is currently $3.62 billion, with the most recent change of +$712.50 million (+24.49%) on 31 December 2023. During the last 3 years, it has risen by +$1.70 billion (+88.01%). DXCM annual revenue is now at all-time high.DXCM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$994.20 M
-$10.10 M-1.01%
30 September 2024
Summary:
DexCom quarterly revenue is currently $994.20 million, with the most recent change of -$10.10 million (-1.01%) on 30 September 2024. Over the past year, it has increased by +$19.20 million (+1.97%). DXCM quarterly revenue is now -3.90% below its all-time high of $1.03 billion, reached on 31 December 2023.DXCM Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$3.95 B
+$19.20 M+0.49%
30 September 2024
Summary:
DexCom TTM revenue is currently $3.95 billion, with the most recent change of +$19.20 million (+0.49%) on 30 September 2024. Over the past year, it has increased by +$551.00 million (+16.19%). DXCM TTM revenue is now at all-time high.DXCM TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.5% | +2.0% | +16.2% |
| 3 y3 years | +88.0% | +52.9% | +70.5% |
| 5 y5 years | +251.1% | +150.9% | +192.6% |
DXCM Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +88.0% | -3.9% | +58.1% | at high | +70.5% |
| 5 y | 5 years | at high | +251.1% | -3.9% | +150.9% | at high | +192.6% |
| alltime | all time | at high | >+9999.0% | -3.9% | >+9999.0% | at high | >+9999.0% |
DexCom Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $994.20 M(-1.0%) | $3.95 B(+0.5%) |
| June 2024 | - | $1.00 B(+9.0%) | $3.93 B(+3.5%) |
| Mar 2024 | - | $921.00 M(-11.0%) | $3.80 B(+5.0%) |
| Dec 2023 | $3.62 B(+24.5%) | $1.03 B(+6.1%) | $3.62 B(+6.4%) |
| Sept 2023 | - | $975.00 M(+11.9%) | $3.40 B(+6.4%) |
| June 2023 | - | $871.30 M(+17.5%) | $3.20 B(+5.8%) |
| Mar 2023 | - | $741.50 M(-9.0%) | $3.02 B(+3.9%) |
| Dec 2022 | $2.91 B(+18.8%) | $815.20 M(+5.9%) | $2.91 B(+4.2%) |
| Sept 2022 | - | $769.60 M(+10.5%) | $2.79 B(+4.5%) |
| June 2022 | - | $696.20 M(+10.7%) | $2.67 B(+3.9%) |
| Mar 2022 | - | $628.80 M(-9.9%) | $2.57 B(+5.1%) |
| Dec 2021 | $2.45 B(+27.1%) | $698.20 M(+7.4%) | $2.45 B(+5.6%) |
| Sept 2021 | - | $650.20 M(+9.3%) | $2.32 B(+6.9%) |
| June 2021 | - | $595.10 M(+17.8%) | $2.17 B(+7.1%) |
| Mar 2021 | - | $505.00 M(-11.2%) | $2.03 B(+5.2%) |
| Dec 2020 | $1.93 B(+30.5%) | $568.90 M(+13.6%) | $1.93 B(+5.8%) |
| Sept 2020 | - | $500.90 M(+10.9%) | $1.82 B(+6.1%) |
| June 2020 | - | $451.80 M(+11.5%) | $1.72 B(+7.2%) |
| Mar 2020 | - | $405.10 M(-12.5%) | $1.60 B(+8.4%) |
| Dec 2019 | $1.48 B(+43.1%) | $462.80 M(+16.8%) | $1.48 B(+9.2%) |
| Sept 2019 | - | $396.30 M(+17.8%) | $1.35 B(+10.6%) |
| June 2019 | - | $336.40 M(+19.9%) | $1.22 B(+8.3%) |
| Mar 2019 | - | $280.50 M(-17.0%) | $1.13 B(+9.3%) |
| Dec 2018 | $1.03 B(+43.6%) | $338.00 M(+26.7%) | $1.03 B(+12.8%) |
| Sept 2018 | - | $266.70 M(+10.0%) | $914.60 M(+9.9%) |
| June 2018 | - | $242.50 M(+31.5%) | $832.50 M(+9.5%) |
| Mar 2018 | - | $184.40 M(-16.6%) | $760.60 M(+5.9%) |
| Dec 2017 | $718.50 M(+25.3%) | $221.00 M(+19.7%) | $718.50 M(+7.4%) |
| Sept 2017 | - | $184.60 M(+8.2%) | $668.70 M(+5.7%) |
| June 2017 | - | $170.60 M(+19.9%) | $632.70 M(+5.6%) |
| Mar 2017 | - | $142.30 M(-16.9%) | $599.40 M(+4.6%) |
| Dec 2016 | $573.30 M(+42.6%) | $171.20 M(+15.2%) | $573.30 M(+7.6%) |
| Sept 2016 | - | $148.60 M(+8.2%) | $532.90 M(+8.9%) |
| June 2016 | - | $137.30 M(+18.2%) | $489.50 M(+9.9%) |
| Mar 2016 | - | $116.20 M(-11.2%) | $445.40 M(+10.8%) |
| Dec 2015 | $402.00 M | $130.80 M(+24.3%) | $402.00 M(+13.1%) |
| Sept 2015 | - | $105.20 M(+12.9%) | $355.50 M(+11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | $93.20 M(+28.0%) | $319.30 M(+12.1%) |
| Mar 2015 | - | $72.80 M(-13.6%) | $284.90 M(+9.9%) |
| Dec 2014 | $259.20 M(+62.0%) | $84.30 M(+22.2%) | $259.20 M(+14.4%) |
| Sept 2014 | - | $69.00 M(+17.3%) | $226.60 M(+13.0%) |
| June 2014 | - | $58.80 M(+24.8%) | $200.50 M(+13.0%) |
| Mar 2014 | - | $47.10 M(-8.9%) | $177.50 M(+10.9%) |
| Dec 2013 | $160.00 M(+60.2%) | $51.70 M(+20.5%) | $160.00 M(+13.0%) |
| Sept 2013 | - | $42.90 M(+19.8%) | $141.60 M(+16.3%) |
| June 2013 | - | $35.80 M(+20.9%) | $121.80 M(+11.3%) |
| Mar 2013 | - | $29.60 M(-11.1%) | $109.40 M(+9.5%) |
| Dec 2012 | $99.90 M(+30.9%) | $33.30 M(+44.2%) | $99.90 M(+12.2%) |
| Sept 2012 | - | $23.10 M(-1.3%) | $89.06 M(+5.8%) |
| June 2012 | - | $23.40 M(+16.4%) | $84.21 M(+2.4%) |
| Mar 2012 | - | $20.10 M(-10.5%) | $82.23 M(+7.8%) |
| Dec 2011 | $76.30 M(+57.0%) | $22.45 M(+23.0%) | $76.30 M(+9.9%) |
| Sept 2011 | - | $18.25 M(-14.8%) | $69.45 M(+10.5%) |
| June 2011 | - | $21.42 M(+51.1%) | $62.86 M(+18.1%) |
| Mar 2011 | - | $14.17 M(-9.2%) | $53.23 M(+9.5%) |
| Dec 2010 | $48.60 M(+63.7%) | $15.61 M(+33.8%) | $48.60 M(+11.8%) |
| Sept 2010 | - | $11.66 M(-1.0%) | $43.47 M(+11.3%) |
| June 2010 | - | $11.79 M(+23.5%) | $39.06 M(+14.8%) |
| Mar 2010 | - | $9.54 M(-8.8%) | $34.03 M(+14.6%) |
| Dec 2009 | $29.69 M(+201.8%) | $10.47 M(+44.2%) | $29.69 M(+27.5%) |
| Sept 2009 | - | $7.26 M(+7.5%) | $23.30 M(+29.7%) |
| June 2009 | - | $6.75 M(+29.5%) | $17.96 M(+36.2%) |
| Mar 2009 | - | $5.21 M(+28.0%) | $13.19 M(+34.1%) |
| Dec 2008 | $9.84 M(+112.6%) | $4.07 M(+112.1%) | $9.84 M(+34.9%) |
| Sept 2008 | - | $1.92 M(-3.1%) | $7.29 M(+10.6%) |
| June 2008 | - | $1.98 M(+6.4%) | $6.60 M(+20.4%) |
| Mar 2008 | - | $1.86 M(+21.9%) | $5.48 M(+18.4%) |
| Dec 2007 | $4.63 M(+113.2%) | $1.53 M(+24.8%) | $4.63 M(+17.6%) |
| Sept 2007 | - | $1.22 M(+41.8%) | $3.93 M(+10.8%) |
| June 2007 | - | $863.00 K(-14.7%) | $3.55 M(+12.1%) |
| Mar 2007 | - | $1.01 M(+21.2%) | $3.17 M(+46.0%) |
| Dec 2006 | $2.17 M | $835.00 K(-0.7%) | $2.17 M(+62.6%) |
| Sept 2006 | - | $841.00 K(+75.6%) | $1.33 M(+170.3%) |
| June 2006 | - | $479.00 K(+3136.5%) | $493.80 K(+3236.5%) |
| Mar 2006 | - | $14.80 K | $14.80 K |
FAQ
- What is DexCom annual revenue?
- What is the all time high annual revenue for DexCom?
- What is DexCom annual revenue year-on-year change?
- What is DexCom quarterly revenue?
- What is the all time high quarterly revenue for DexCom?
- What is DexCom quarterly revenue year-on-year change?
- What is DexCom TTM revenue?
- What is the all time high TTM revenue for DexCom?
- What is DexCom TTM revenue year-on-year change?
What is DexCom annual revenue?
The current annual revenue of DXCM is $3.62 B
What is the all time high annual revenue for DexCom?
DexCom all-time high annual revenue is $3.62 B
What is DexCom annual revenue year-on-year change?
Over the past year, DXCM annual revenue has changed by +$712.50 M (+24.49%)
What is DexCom quarterly revenue?
The current quarterly revenue of DXCM is $994.20 M
What is the all time high quarterly revenue for DexCom?
DexCom all-time high quarterly revenue is $1.03 B
What is DexCom quarterly revenue year-on-year change?
Over the past year, DXCM quarterly revenue has changed by +$19.20 M (+1.97%)
What is DexCom TTM revenue?
The current TTM revenue of DXCM is $3.95 B
What is the all time high TTM revenue for DexCom?
DexCom all-time high TTM revenue is $3.95 B
What is DexCom TTM revenue year-on-year change?
Over the past year, DXCM TTM revenue has changed by +$551.00 M (+16.19%)